CalciMedica, Inc.
CALC
$2.06
$0.063.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.89% | -7.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.60% | -12.15% | |||
| Operating Income | -7.60% | 12.15% | |||
| Income Before Tax | 24.21% | -42.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.21% | -42.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.21% | -42.08% | |||
| EBIT | -7.60% | 12.15% | |||
| EBITDA | -7.64% | 12.19% | |||
| EPS Basic | 34.89% | -41.99% | |||
| Normalized Basic EPS | 34.89% | -41.96% | |||
| EPS Diluted | 34.89% | -41.99% | |||
| Normalized Diluted EPS | 34.89% | -41.96% | |||
| Average Basic Shares Outstanding | 16.39% | 0.05% | |||
| Average Diluted Shares Outstanding | 16.39% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||